FI117666B - Fusidihappotablettien valmistus - Google Patents
Fusidihappotablettien valmistus Download PDFInfo
- Publication number
- FI117666B FI117666B FI965214A FI965214A FI117666B FI 117666 B FI117666 B FI 117666B FI 965214 A FI965214 A FI 965214A FI 965214 A FI965214 A FI 965214A FI 117666 B FI117666 B FI 117666B
- Authority
- FI
- Finland
- Prior art keywords
- tablets
- fusidic acid
- granules
- sodium salt
- bulk density
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 239000002253 acid Substances 0.000 title 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 claims abstract description 26
- 229960004675 fusidic acid Drugs 0.000 claims abstract description 26
- 239000008187 granular material Substances 0.000 claims abstract description 20
- 238000009505 enteric coating Methods 0.000 claims abstract description 9
- 239000002702 enteric coating Substances 0.000 claims abstract description 9
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 159000000000 sodium salts Chemical class 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000005549 size reduction Methods 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- -1 hydroxypropylmethyl Chemical group 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Formation And Processing Of Food Products (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9415048A GB9415048D0 (en) | 1994-07-26 | 1994-07-26 | Tablet |
| GB9415048 | 1994-07-26 | ||
| EP9502904 | 1995-07-21 | ||
| PCT/EP1995/002904 WO1996003128A1 (en) | 1994-07-26 | 1995-07-21 | Preparation of fusidic acid tablets |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI965214A0 FI965214A0 (fi) | 1996-12-27 |
| FI965214L FI965214L (fi) | 1996-12-27 |
| FI117666B true FI117666B (fi) | 2007-01-15 |
Family
ID=10758888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI965214A FI117666B (fi) | 1994-07-26 | 1996-12-27 | Fusidihappotablettien valmistus |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0773783B1 (cs) |
| JP (1) | JP3853358B2 (cs) |
| KR (1) | KR100358614B1 (cs) |
| CN (1) | CN1070703C (cs) |
| AT (1) | ATE209496T1 (cs) |
| AU (1) | AU681980B2 (cs) |
| CA (1) | CA2193235C (cs) |
| CZ (1) | CZ286197B6 (cs) |
| DE (1) | DE69524226T2 (cs) |
| DK (1) | DK0773783T3 (cs) |
| ES (1) | ES2163521T3 (cs) |
| FI (1) | FI117666B (cs) |
| GB (1) | GB9415048D0 (cs) |
| HU (1) | HU221483B (cs) |
| NZ (1) | NZ290806A (cs) |
| PL (1) | PL180935B1 (cs) |
| PT (1) | PT773783E (cs) |
| RO (1) | RO118633B1 (cs) |
| RU (1) | RU2140272C1 (cs) |
| WO (1) | WO1996003128A1 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2301282A1 (en) * | 1997-08-20 | 1999-02-25 | Pradeepkumar P. Sanghvi | Process for improving flow and compression of tableting compositions |
| RU2240781C1 (ru) * | 2003-06-05 | 2004-11-27 | Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии | Способ лечения воспалительных процессов вульвы и влагалища |
| KR20140079867A (ko) | 2005-10-31 | 2014-06-27 | 레오 파마 에이/에스 | 결정성 항생 물질의 제조 |
| FR2895908B1 (fr) * | 2006-01-12 | 2008-03-28 | France Etat | Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir |
| JP5249568B2 (ja) * | 2007-12-06 | 2013-07-31 | 旭化成ケミカルズ株式会社 | 成形用粉末、およびこれを用いた圧縮成形組成物、ならびに成形用粉末の製造方法 |
| DE102008051783A1 (de) * | 2008-10-17 | 2010-04-22 | Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg | Valsartan enthaltende Tablette |
| EP2382968A1 (en) | 2010-03-26 | 2011-11-02 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Particle size distribution of fusidic acid granules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7411402A (nl) * | 1973-09-13 | 1975-03-17 | Leo Pharm Prod Ltd | Werkwijze voor het bereiden van een middel tegen arthritis. |
| EP0300073A1 (en) * | 1987-07-22 | 1989-01-25 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Use of fusidic acid in the treatment of aids-related complex and full-blown aids |
-
1994
- 1994-07-26 GB GB9415048A patent/GB9415048D0/en active Pending
-
1995
- 1995-07-21 EP EP95927705A patent/EP0773783B1/en not_active Expired - Lifetime
- 1995-07-21 HU HU9700217A patent/HU221483B/hu unknown
- 1995-07-21 CZ CZ1997229A patent/CZ286197B6/cs not_active IP Right Cessation
- 1995-07-21 NZ NZ290806A patent/NZ290806A/en not_active IP Right Cessation
- 1995-07-21 RU RU97102767A patent/RU2140272C1/ru active
- 1995-07-21 DK DK95927705T patent/DK0773783T3/da active
- 1995-07-21 DE DE69524226T patent/DE69524226T2/de not_active Expired - Lifetime
- 1995-07-21 RO RO97-00127A patent/RO118633B1/ro unknown
- 1995-07-21 CN CN95194320A patent/CN1070703C/zh not_active Expired - Lifetime
- 1995-07-21 KR KR1019970700432A patent/KR100358614B1/ko not_active Expired - Lifetime
- 1995-07-21 ES ES95927705T patent/ES2163521T3/es not_active Expired - Lifetime
- 1995-07-21 JP JP50546296A patent/JP3853358B2/ja not_active Expired - Lifetime
- 1995-07-21 AU AU31644/95A patent/AU681980B2/en not_active Expired
- 1995-07-21 AT AT95927705T patent/ATE209496T1/de active
- 1995-07-21 PT PT95927705T patent/PT773783E/pt unknown
- 1995-07-21 WO PCT/EP1995/002904 patent/WO1996003128A1/en active IP Right Grant
- 1995-07-21 CA CA002193235A patent/CA2193235C/en not_active Expired - Lifetime
- 1995-07-21 PL PL95318261A patent/PL180935B1/pl unknown
-
1996
- 1996-12-27 FI FI965214A patent/FI117666B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT773783E (pt) | 2002-04-29 |
| NZ290806A (en) | 1998-01-26 |
| CN1154066A (zh) | 1997-07-09 |
| EP0773783B1 (en) | 2001-11-28 |
| AU3164495A (en) | 1996-02-22 |
| PL180935B1 (pl) | 2001-05-31 |
| CA2193235C (en) | 2008-03-18 |
| ATE209496T1 (de) | 2001-12-15 |
| PL318261A1 (en) | 1997-05-26 |
| CA2193235A1 (en) | 1996-02-08 |
| KR970704447A (ko) | 1997-09-06 |
| FI965214A0 (fi) | 1996-12-27 |
| CZ286197B6 (cs) | 2000-02-16 |
| HU9700217D0 (en) | 1997-04-28 |
| CZ22997A3 (en) | 1997-04-16 |
| ES2163521T3 (es) | 2002-02-01 |
| FI965214L (fi) | 1996-12-27 |
| RO118633B1 (ro) | 2003-08-29 |
| EP0773783A1 (en) | 1997-05-21 |
| RU2140272C1 (ru) | 1999-10-27 |
| GB9415048D0 (en) | 1994-09-14 |
| DK0773783T3 (da) | 2002-04-02 |
| JP3853358B2 (ja) | 2006-12-06 |
| KR100358614B1 (ko) | 2003-01-10 |
| DE69524226D1 (de) | 2002-01-10 |
| AU681980B2 (en) | 1997-09-11 |
| DE69524226T2 (de) | 2002-06-27 |
| CN1070703C (zh) | 2001-09-12 |
| JPH10502937A (ja) | 1998-03-17 |
| HUT76836A (en) | 1997-11-28 |
| WO1996003128A1 (en) | 1996-02-08 |
| HU221483B (en) | 2002-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2204996C2 (ru) | Таблетка, быстро распадающаяся в щечном кармане, и способ ее изготовления | |
| SU1577684A3 (ru) | Способ получени таблеток | |
| UA72922C2 (uk) | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З <font face="Symbol">b</font>-КАРБОЛІНОМ (ВАРІАНТИ) ТА СПОСІБ ЛІКУВАННЯ СЕКСУАЛЬНОЇ ДИСФУНКЦІЇ | |
| CN107875136B (zh) | 一种阿莫西林药物制剂及其制备方法 | |
| US8834923B2 (en) | Slow-release composition, method for the preparation thereof, and use thereof | |
| US6291462B1 (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates | |
| NZ236834A (en) | Oral medicaments comprising pimobendan in dry mixture with citric acid | |
| FI117666B (fi) | Fusidihappotablettien valmistus | |
| FI89238C (fi) | Foerfarande foer framstaellning av kompressionsbelagda tabletter | |
| UA27954C2 (uk) | Біологічно активна речовина фармацевтичної композиції для лікування гіперглікемій та фармацевтична композиція з протигіперглікемічною активністю | |
| FI71314C (fi) | Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt | |
| CA1268706A (en) | Method for simultaneously drying and granulating extract substances from deproteinized calves blood | |
| MX2011000709A (es) | Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes. | |
| HU194217B (en) | Process for producing pharmaceutical compositions containing basic piroxicam salts and pharmaceutically acceptable solide vehicle | |
| CN112057427A (zh) | 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法 | |
| RU2183121C1 (ru) | Фармацевтическая композиция, обладающая снотворной, седативной и транквилизирующей активностью, способ ее получения | |
| RU2190407C1 (ru) | Способ получения противовирусного средства | |
| RU2188017C1 (ru) | Способ получения таблеток комбинированного препарата триметоприма с сульфаметоксазолом | |
| JP2000007585A (ja) | 耐湿性固形製剤及びその製造方法 | |
| CA2026384C (en) | A solid drug form with a high verapamil content | |
| RU2224521C2 (ru) | Твердая лекарственная форма, обладающая транквилизирующим действием, и способ ее изготовления | |
| RU2275910C2 (ru) | Способ изготовления таблеток покрытых оболочкой, обладающих церебропротекторным, антиоксидантным и ноотропным действием | |
| RU2203056C1 (ru) | Способ получения твердой лекарственной формы препарата на основе дибазола | |
| RU2228751C1 (ru) | Антипротозойная фармацевтическая композиция | |
| RU2171673C1 (ru) | Фармацевтическая композиция и способ ее получения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 117666 Country of ref document: FI |
|
| MA | Patent expired |